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1. Introduction
Hot flashes are associated with menopause or hor-
monal changes that accompany certain treatments, 
such as androgen deprivation therapy for prostate 
cancer and estrogen antagonist therapy after breast 
cancer surgery [1−4]. Although the prevalence of hot 
flashes is unknown, many young patients who ex-
perience hot flashes but have no significant medi-
cal disorders are seen in clinical practice. Hormone 
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replacement therapy, which is the standard treat-
ment for hot flashes, carries a substantial risk of 
cardiovascular disease and breast cancer [5]. Thus, 
nonhormonal alternatives, including lifestyle modi-
fication, exercise, acupuncture, and herbal reme-
dies (e.g., phytoestrogen and herbal treatments) are 
widely used. Considerable clinical evidence for these 
interventions has been recently assessed [6−10]. 
Gui-zhi-fu-ling-wan (GFW) is an herbal formula con-
sisting of five herbs. GFW has been widely used to 
130 K.H. Cho et al
treat hot flashes in Korea, China and Japan. Previous 
studies have reported that GFW improves the hot 
flashes of menopausal women [11], possibly by in-
creasing calcitonin gene-related peptide (CGRP) 
activity. GFW inhibited CGRP-induced elevation of 
skin temperature without restoring serum estrogen 
in rats that had undergone ovariectomies [12]. In 
this study, we evaluated the effectiveness of GFW 
for treating hot flashes in young patients.
2. Methods and Methods
2.1. Inclusion criteria
We reviewed the medical records of outpatients 
who visited the clinic of a traditional Korean me-
dical doctor in the Department of Cardiovascular 
and Neurologic Disease (Stroke Center), Kyung Hee 
Oriental Medical Center, Seoul, Korea, for hot flashes 
from October 1, 2003 to October 1, 2008. Inclusion 
criteria were as follows: frequent temporal sensa-
tions of heat for at least 1 month; age between 18 
and 55 years old; no serious medical diseases with 
symptoms that included hot flashes (e.g., prostate 
cancer, breast cancer); and no medications or treat-
ments for hot flashes. The sex of the patient was not 
a criterion for study inclusion.
2.2. Exclusion criteria
We excluded patients who were in menopause, had 
serious diseases, or had undergone medical proce-
dures such as surgery on sex organs, which could 
induce hormonal changes. Patients whose medical 
records were incomplete were also excluded.
2.3. Administration of GFW
The patients were prescribed dry GFW extract pow-
der (5.0−7.5 g/day; Tsumura & Co. Ltd., Japan) ac-
cording to the severity of symptoms, taking into 
account conditions such as digestive function and 
body strength. Each 7.5 g GFW contained 1.75 g 
extract mixture composed of equal amounts of 
Cinnamomum cortex, Paeoniae radix, Moutan cor-
tex, Hoelen, and Persicae semen [12]. The remain-
ing 5.75 g consisted of light anhydrous silicic acid, 
stearic acid, magnesium, and lactose hydrate used 
as excipients. GFW extract was administered orally 
two or three times a day.
2.4. Evaluation and outcome variables
The medication’s effectiveness was estimated from 
changes in the number and severity of hot flashes 
compared with baseline. Patients evaluated their 
Table 1  Diagnostic criteria for blood stasis syndrome 
[12]
Symptom 
Score
 Men Women
Dark-rimmed eyes 10 10
Areas of dark pigmentation on face 2 2
Rough skin 2 5
Livid lips 2 2
Livid gingiva 10 5
Livid tongue 10 10
Telangiectasis/spider veins 5 5
Subcutaneous hemorrhage 2 10
Palmar erythema 2 5
Resistance and tenderness on pressure 5 5
 of the left paraumbilical region
Resistance and tenderness on pressure 10 10
 of the right paraumbilical region
Resistance and tenderness on 5 5
 pressure of the umbilical region
Resistance and/or tenderness on 5 2
 pressure of the ileocecal region
Resistance and/or tenderness on 5 5
 pressure of the sigmoidal region
Resistance and/or tenderness on 5 5
 pressure of the subcostal region
Hemorrhoids 10 5
Dysmenorrhea − 10
Total score > 20 indicates blood stasis syndrome.
experiences using a 100-mm visual analog scale 
(VAS). Cure rate was also evaluated. Results were 
classified into five groups: remarkably effective (RE, 
VAS score improvement > 75), more than effective 
(ME, VAS score improvement of 50−75), effective (EF, 
VAS score improvement of 25−50), not effective (NE, 
VAS score improvement < 25), or aggravating (AG, no 
improvement or worsening of VAS score). Responders 
were defined as the patients whose VAS scores im-
proved by more than 50%. Safety was assessed by the 
type and frequency of adverse events, which were 
classified as none, mild, or severe.
To determine the relationship between hot flashes 
and blood stasis syndrome, the blood stasis score 
was determined according to Terasawa’s “Oketsu” 
scoring system (Table 1) [13]. During the physician’s 
four examinations, cold syndrome and hot syndrome 
were also diagnosed.
2.5. Statistical analysis
SPSS 12.0 for Windows (SPSS Inc., Chicago, IL, USA) 
was used for statistical analysis. The Mann-Whitney 
U test was used for comparisons between men and 
women, hot and cold syndrome groups, and blood 
stasis syndrome (BSS) and non-blood stasis syndrome 
Gui-zhi-fu-ling-wan for hot flashes in young patients 131
(NBSS) groups, because these data were not nor-
mally distributed. Correlation analysis was used to 
examine the relationship between VAS improvement 
and other factors (age, number of visits, total medi-
cation days, and duration of hot flashes).
3. Results
3.1. Patient characteristics
We reviewed the medical records of 60 patients; 
23 patients were excluded because of inadequate 
medical records. Thirty-seven patients were included 
in the analysis. The mean age was 32.3 ± 10.3 years 
(mean ± SD), and the duration of hot flashes was 
7.2 ± 6.4 years. Twenty-two patients were women, 
and 15 were men. Most of the patients were white-
collar workers, two patients were soldiers, and three 
were unemployed.
There were several accompanying symptoms: 
sweating (n = 4), cold hands and feet (n = 4), sleep 
disturbance (n = 3), and other (n = 4). On average, 
patients visited the clinic 3.4 ± 1.5 times and took 
GFW for 128 ± 103.2 days.
3.2. Effectiveness assessment
Mean VAS score improvement was 40.4 ± 28.5; 19 
(51.3%) of the patients were classified as respond-
ers (Table 2). There was no difference between 
men and women in terms of effectiveness (Mann-
Whitney U test, z = −0.670, p = 0.503). The total 
number of days of herbal formula use was posi-
tively correlated with its effectiveness (Spearman’s 
r = 0.452, p = 0.005), but the total visiting days, dura-
tion of symptoms, and age showed little or no cor-
relation with the change in VAS score (Spearman’s 
r = 0.279, −0.180, and −0.064, respectively; p = 0.095, 
0.317, and 0.695, respectively).
3.3.  Comparison of effectiveness 
between cold syndrome group and 
hot syndrome group
Twelve patients received a diagnosis of cold syn-
drome, and 12 patients received a diagnosis of 
hot syndrome. This diagnosis did not influence VAS 
score improvement (Mann-Whitney U test, z = − 0.602, 
p = 0.547).
3.4.  Comparison of effectiveness between 
blood stasis syndrome group and 
non-blood stasis syndrome group
We compared VAS score improvement between the 
BSS group (n = 5) and the NBSS group (n = 4) and de-
tected no statistical difference between the groups 
(z = −0.809, p = 0.418).
3.5. Safety assessment
Adverse events were reported in two patients (5.4%). 
In one case, treatment was terminated immediately 
because of itching and edema. The other patient 
reported a mild adverse event of dyspepsia and 
constipation.
4. Discussion
Hormonal changes such as those that occur during 
menopause are considered to be the main causes 
of hot flashes. Alternative therapy has been shown 
to be useful in treating hot flashes [6]. In tradi-
tional Chinese medicine, GFW is generally used for 
hot flashes. Previous studies have reported the ef-
fectiveness of GFW for treating hot flashes, but most 
focused on menopausal patients. In the present study 
we evaluated GFW for treating hot flashes in young 
patients who have no serious medical problems.
We found GFW to be effective in 81% of patients 
(Table 1). Moreover, about 51% of patients were 
responders. Patients who took GFW for more than 
100 days experienced better relief of symptoms; 
however, patient age or duration of symptoms did not 
correlate with VAS score improvement. Traditional 
Chinese medicine recognizes numerous syndromes 
that exhibit various symptoms. Hot syndrome or cold 
syndrome was diagnosed based on the patient’s symp-
toms; however, the diagnosis of hot or cold syndrome 
did not influence VAS score improvement in this 
study. GFW is usually prescribed for patients who 
have BSS; however, no significant difference was 
detected in the improvement of VAS scores between 
the BSS and NBSS groups. This result may be due in 
part to the exclusion of patients whose medical 
records (n = 28) did not contain sufficient informa-
tion to diagnose BSS.
The physical mechanism of GFW’s effect on hot 
flashes is uncertain. However, GFW regulates the 
elevation of skin temperature induced by CGRP with-
out estrogen activation [14,15]. The mechanism 
by which GFW treats hot flashes is not related to 
Table 2 Assessment of Gui-zhi-fu-ling-wan treatment
Cases (n) 
Effectiveness, n (%)
 RE ME EF NE AG
37 9 (24) 10 (26) 11 (30) 7 (20) 0 (0)
RE = remarkably effective; ME = more than effective; EF = 
effective; NE = not effective; AG = aggravating.
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estrogen; therefore, adverse effects associated with 
estrogen can be avoided when treating hot flashes 
with GFW.
GFW is one of the treatments for blood stasis 
established by Zhang Zhongjing. Originally, it was 
used to activate the blood and eliminate masses for 
women who had aggregation−accumulation con-
ditions [16]. In this context, GFW might be used to 
treat hot flashes in young patients. Such hot flashes 
were thought to typically originate in the stagnation 
of qi and blood in cases of liver qi depression and 
liver−spleen disharmony.
Itching and edema, which were reported by one 
patient, could be explained by P. radix, an herbal 
component of GFW, which may induce hepatotox-
icity and elicit a hypersensitivity reaction [17,18]. 
Dyspepsia may be related to the inhibitory action 
of P. radix on gastric acid [19]. However, no severe 
adverse events and only a small number of minor 
adverse events were reported in this study. There-
fore, GFW was shown to be relatively safe in this 
small preliminary study.
The putative relationship between physical ac-
tivity and hot flashes is controversial [7,20]. Heavy 
physical activity induces vasodilatation and makes 
hot flashes more intense. However, in our study most 
of the patients were white-collar workers. Stress 
from mental exertion can induce qi stagnation, 
which may account for hot flashes experienced by 
white-collar workers [21].
Seventeen patients were not included in this 
study, because they visited the doctor only once. 
In a follow-up telephone interview, two replied 
that GFW did not work for them. This retrospec-
tive case study has many limitations. First, this 
study did not include a control group, and only a 
small number of cases were used for the analysis; 
therefore, the effects of GFW for treating hot flashes 
cannot be precisely determined from these data. 
Second, this study has methodological flaws, such 
as the absence of objective outcomes and the lack 
of a consistent endpoint. We depended primarily on 
assessments of medical history and determined symp-
tom improvement using subjective self-reporting 
by patients without hormonal evaluation. Different 
endpoints for assessing hot flashes in each patient 
preclude the use of these findings for obtaining 
conclusive evidence of the effects of GFW. Never-
theless, case studies or case series have value, be-
cause they provide the rationale for clinical trials. 
Despite its limitations, this study provides some 
basic knowledge regarding the clinical effective-
ness of GFW in young patients. Rigorous clinical 
trials are needed to evaluate the effectiveness of 
herbal treatments including GFW for treating hot 
flashes in young patients.
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